Taysha Gene Therapies, Inc. TSHA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$42.41M-97.0% | -$27.85M-48.3% | -$32.73M-28.2% | -$26.88M-28.4% | -$21.53M+10.5% | ||
| $295K+4.2% | $299K-1.6% | $200K-33.3% | $300K0.0% | $283K-12.9% | ||
| $5.55M+68.4% | $3.53M+9.7% | $3.29M-2.1% | $3.19M-4.3% | $3.29M+3.0% | ||
| -$40.88M-85.6% | -$26.72M-46.0% | -$24.17M-11.8% | -$20.18M+6.1% | -$22.02M-11.2% | ||
| $24K-93.7% | $250K— | $108K+209% | $2K-99.0% | $378K+170% | ||
| -$3.02M-715% | -$247K— | -$48K-37.1% | —— | -$371K-165% | ||
| $711K+1,467% | $49.56M— | $8.8M+33.4% | $216.29M+207% | -$52K-136% | ||
| -$43.19M-92.4% | $22.59M+221% | $0+100% | $196.17M+302% | -$22.44M-12.4% | ||
| -$40.9M-82.6% | -$26.97M-47.3% | -$24.27M-12.1% | -$20.18M+7.0% | -$22.4M-12.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Taysha Gene Therapies, Inc. generate?
- Taysha Gene Therapies, Inc. (TSHA) generated -$111.9M in operating cash flow over the trailing twelve months.
- What is Taysha Gene Therapies, Inc.'s free cash flow?
- After $384.0K of capital expenditures, Taysha Gene Therapies, Inc.'s free cash flow was -$112.3M over the trailing twelve months, down 33.6% year over year.
- Where does Taysha Gene Therapies, Inc.'s cash flow data come from?
- Every line is extracted from Taysha Gene Therapies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
